Cancel

The Oncologist: Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis

Learning Objectives: 1. Formulate a plan to follow up patients with lymphomatoid papulosis during an appropriate period in order to diagnose and treat associated lymphomas that decrease the prognosis of LyP. 2. Use identified risk factors to select lymphomatoid papulosis patients who require a close management.ma of the breast. Background. Lymphomatoid papulosis (LyP) is classified as an indolent cutaneous lymphoma, but outcome dramatically worsens if LyP is associated with lymphoma. The...
Society For Translational Oncology

Clinical and Multidisciplinary Hematology & Oncology: The 15th Annual Review

This course will include a comprehensive update and management strategies of issues in hematologic and oncologic malignancies presenting new disease classification, treatment, and challenging cases. Course topics will focus on key hematologic diseases (dysproteinemias, acute and chronic leukemias, lymphomas), key solid tumors (breast, thoracic, GI, GU), and overlap topics of supportive, ancillary and diagnostic care. The course offers challenging and interactive sessions on pertinent issues in...
Mayo Clinic

Principles and Clinical Applications of Flow Cytometry, 4th Edition (CE)

This course includes two major parts. The first part concerns technical principles, including the structure and mechanism of instrumentation and quality control. The second part discusses clinical applications of flow cytometry, including immunophenotyping of hematologic neoplasms, lymphocyte subset analysis for immunodeficiency states, DNA analysis for hematologic neoplasms and solid tumors, and reticulocyte counting. After completing the course, participants should be able to understand how ...
CACMLE

The Oncologist: US Food and Drug Administration Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1

Learning Objectives: 1. Describe variables associated with pembrolizumab antitumor activity in patients with metastatic non-small cell lung cancer 2. Review outcomes for patients with metastatic non-small cell lung cancer treated with pembrolizumab Outline potential adverse events associated with pembrolizumab treatment On October 2, 2015, the U.S. Food and Drug Administration (FDA) granted accelerated approval for pembrolizumab, a breakthrough therapy-designated drug, for the treatment ...
Society For Translational Oncology

The Oncologist: FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

Learning Objectives: 1. Discuss evaluation of patients with non-squamous NSCLC for ALK and EGFR gene alterations and initial treatment for those with ALK- or EGFR-positive NSCLC. 2. Describe a treatment plan for non-squamous NSCLC patients without actionable mutations at first and after disease progression. On October 9, 2015, the U.S. Food and Drug Administration expanded the nivolumab metastatic non-small cell lung cancer (NSCLC) indication to include patients with nonsquamous NSCLC aft...
Society For Translational Oncology

Dermatology: Principles and Practice Strategies for the Primary Care Office

***COURSE OUTLINE*** “Cases That Have Taught Me a Lesson.” (Miller) Acne, Part I: Pathosphysiology, Recognition an Treatment. (Maroon) Acne, Part II: Identification and Treatment of Acne, Acneiform Eruptions and Rosacea. (Maroon) Case Studies in Dermatology. (Maroon) Common Problems in Office Dermatology. (Miller) Common Tumors in the Office Setting, Part I: Warts, Mollusca, Fibrous Tumors, Cutaneous Horns, Acanthomas. (Maroon) Common Tumors in the Office Setti...
American Medical Seminars

The Oncologist: Cancer Incidence in First and Second Degree Relatives of BRCA1 and BRCA2 Mutation Carriers

Learning Objectives: 1. Discuss known risks of cancers in BRCA1 and BRCA2 mutation carriers. 2. Cite data from a single institution regarding other cancers described in families of known BRCA mutation carriers. Background. Mutations in the BRCA1 and BRCA2 genes are associated with increased risk of breast, ovarian, and several other cancers. The purpose of the present study was to evaluate the incidence of cancer in first- and second-degree relatives of BRCA mutation carriers compared wi...
Society For Translational Oncology

Pathology CME Online Bundle: Three Review Programs - Journal Summaries - $1,000 Amazon.com Gift Card

The Pathology CME Online Bundle features: • From CMEinfo - Three specialty reviews with 49 lectures covering topics in dermatopathology, gastrointestinal and breast pathology • From Practical Reviews - A one-year subscription, including the FREE mobile app • A $1,000 Amazon.com gift card Topics include: Melanoma, Neoplastic Dermatopathology, Alopecia, Melanocytic Lesions, B cell Lymphomas, Nonneoplastic Colorectal Pathology, Polyposis Syndromes, Small Intestinal Neoplasms, Invas...
CMEInfo

Audio Digest Oncology Platinum One Year Membership with Free $1,000 Gift Card

Audio Digest Oncology Platinum One Year Membership with Free $1,000 Gift Card includes: Audio Digest Library - Unlimited access to over 4,000 accredited courses, presented by experts from over 120 leading institutions. Listen to relevant courses from over 500+ topic areas to cover your unique learning requirements or interests.  Recent topics in Audio Digest Oncology include: Oncologic Emergencies, Management of Lymphoma, Lung Cancer, Mesothelioma, Update on Prostate Cancer, Cancer in Wome...
Audio Digest

Audio Digest Oncology Platinum Two Year Membership with Free $2,000 Gift Card

Audio Digest Oncology Platinum Two Year Membership with Free $2,000 Gift Card includes: Audio Digest Library - Unlimited access to over 4,000 accredited courses, presented by experts from over 120 leading institutions. Listen to relevant courses from over 500+ topic areas to cover your unique learning requirements or interests.  Recent topics in Audio Digest Oncology include: Oncologic Emergencies, Management of Lymphoma, Lung Cancer, Mesothelioma, Update on Prostate Cancer, Cancer in Wome...
Audio Digest

Scale, Bail, or Fail – The CDK4/6 Inhibition Edition

Preclinical and clinical findings suggest that CDK4/6 inhibition may confer therapeutic benefits in numerous tumor types and improve outcomes in patients with mantle cell lymphoma, liposarcoma, melanoma, and non–small cell lung cancer. Additionally, studies of CDK4/6 inhibition of cancers of the prostate, lung, skin, and central nervous system are currently under way. In the format of an entertaining (but challenging!) interactive game, this edition of Scale, Bail or Fail presents and dis...
University of Cincinnati and RedMedEd

The Oncologist: Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis

Learning Objectives: 1. Explain prevalent standards of therapy in Waldenström macroglobulinemia in the United States. 2. Describe changes in the presentation, treatment, and survival of older patients with Waldenström macroglobulinemia over the past 15 years. 3. Develop a balanced concept of value associated with novel therapies in Waldenström macroglobulinemia in the context of their potential survival benefits and costs. Introduction. Waldenström macroglobulinemia/lymphoplasmacyti...
Society For Translational Oncology

Penn Radiology Oncologic Imaging: Optimizing Patient Care (Streaming Online & DVD-ROM)

Penn Radiology joins forces with its experts in Nuclear Medicine, Gastroenterology, Pulmonology, Radiation and Interventional Oncology to present this comprehensive review of Oncologic Imaging. Best practices and clinical correlates will be discussed, with two detailed sessions dedicated to CT screening for lung cancer. Credits for this program can be applied toward your Self Assessment CME Requirements for ABR Maintenance of Certification. Topics: CT Screening for Lung Cancer, State of th...
Meetings By Mail®

Penn Radiology Oncologic Imaging: Optimizing Patient Care

Meetings by Mail presents Penn Radiology Oncologic Imaging: Optimizing Patient Care. This comprehensive review of Oncologic Imaging features discussions regarding best practices and clinical correlates, with two detailed sessions dedicated to CT screening for lung cancer.  Other topics include: state of the art and emerging techniques, head and neck cancer, thoracic, GI and other abdominal Malignancies, neuroendocrine tumors, lymphoma, melanoma and MSK. Available in Online Streaming and DVD...
Meetings by Mail

The Brigham Board Review in Hematology

Topics covered by The Brigham Board Review in Hematology include:  Hematopoietic Stem Cell Transplantation, Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative Syndromes, Hodgkin's Lymphoma, Bone Marrow Failure, Hemophagocytic Syndromes, Sickle Cell Disease, Thalassemia and many others. After completing The Brigham Board Review in Hematology, you will be able to: • Apply current/recommended Hematology guidelines in clinical practice • Perform differential diagnosis of comple...
CMEInfo

The Brigham Board Review in Hematology and Oncology

Get ready for the ABIM exam in Hematology-Oncology by studying this Brigham Board Review in Hematology and Oncology. Topics covered by the Brigham Board Review in Hematology and Oncology include: Molecular Genetics of Cancer, Cancer Drug Development, Hematopoietic Stem Cell Transplantation, Acute Leukemias, Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin's Lymphoma, B Cell Malignancies, Mesothelioma, Thyroid Cancer and dozens of others. After completing the Brigham Board Review in Hemat...
CMEInfo

Radiation Oncology - A Comprehensive Review: Oakstone Clinical Update

Topics covered in Radiation Oncology include: New Modalities, Central Nervous System Tumors, Head and Neck Tumors, Thoracic Tumors, Upper Gastrointestinal Tumors, Liver Stereotactic Body Radiation Therapy, Soft Tissue Sarcomas. Lymphomas and many others. After studying Radiation Oncology, you will be better able to: • Define the initial clinical evaluation of a patient - using physical exam, history, relevant diagnostic studies, and communication with referring and other physicians involve...
CMEInfo

Clinical Competence in Breast MR, vol. 2

Clinical Competence in Breast MR, vol. 2 contains 100 new comprehensive Breast MR cases, including patient histories, hundreds of images, dynamic sequences and detailed explanations.†The case review explores the many indications for malignant and benign disease, featuring nodules, tumors and patterns of enhancement encountered in every day practice. ††Lectures in indications, techniques and the recognition and report of Breast cancer are also included.. This course meets the case require...
Meetings by Mail

Osler Radiation Oncology Online Review

The Osler Institute utilized state of the art equipment to record the comprehensive Radiation Oncology Review Course and bring it to you! These audio files are stored “in the cloud” so you can stream them anywhere, anytime, as long as you have an internet connection – your learning experience is almost like being at the live activity, but without travel costs and time away from your practice. The Osler Radiation Oncology Review also offers a variety of live Radiation Oncology board revie...
Osler Institute

Osler Surgery MOC Online Review

The Osler Institute utilized state of the art equipment to record the comprehensive Radiation Oncology Review Course and bring it to you! These audio files are stored “in the cloud” so you can stream them anywhere, anytime, as long as you have an internet connection – your learning experience is almost like being at the live activity, but without travel costs and time away from your practice. The Osler Radiation Oncology Review also offers a variety of live Radiation Oncology board revie...
Osler Institute

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.